Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
298
-
Total 13F shares, excl. options
-
54,642,029
-
Shares change
-
+1,476,381
-
Total reported value, excl. options
-
$7,995,182,996
-
Value change
-
+$210,110,873
-
Put/Call ratio
-
229%
-
Number of buys
-
145
-
Number of sells
-
-143
-
Price
-
$146.25
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2017
373 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2017.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 298 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,642,029 shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (8,281,794 shares), FMR LLC (8,042,584 shares), VANGUARD GROUP INC (4,735,774 shares), BlackRock Inc. (2,879,315 shares), JPMORGAN CHASE & CO (1,672,733 shares), Bank of New York Mellon Corp (1,486,425 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,438,481 shares), Senator Investment Group LP (1,300,000 shares), RENAISSANCE TECHNOLOGIES LLC (1,216,100 shares), and Viking Global Investors LP (1,197,466 shares).
This table shows the top 298 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.